22157.jpg
Global Blood-Grouping Reagents Market Report 2024-2028, Featuring AliveDX, Atlas Medical, BAG Health Care, Calibre Scientific, Novacyt, QuidelOrtho, Rapid Labs, Paragon Care and VitroScient
April 18, 2024 11:14 ET | Research and Markets
Dublin, April 18, 2024 (GLOBE NEWSWIRE) -- The "Global Blood-Grouping Reagents Market 2024-2028" report has been added to ResearchAndMarkets.com's offering. The latest market analysis predicts...
Emergen logo.png
Global Blood Management and Diagnostics Market Size to Reach USD 7.48 Billion in 2032 | Emergen Research
September 26, 2023 10:10 ET | Emergen Research
Vancouver, Sept. 26, 2023 (GLOBE NEWSWIRE) -- The global Blood Management and Diagnostics Market size was USD 4.40 Billion in 2022 and is expected to register a steady revenue CAGR of 5.4% during...
TIP_link_300x300.jpg
Blood Transfusion Diagnostics Market Hit $6.48Bn, Globally, by 2028 Growing at 6.9% CAGR, Says The Insight Partners
July 27, 2022 10:30 ET | The Insight Partners
New York, July 27, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on "Blood Transfusion Diagnostics Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by...
Quotient Limited logo
Quotient Limited Announces CFO Transition
November 02, 2016 16:15 ET | Quotient Limited
JERSEY, Channel Islands, Nov. 02, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, announced today that the company and Stephen Unger, Chief Financial...
Quotient Limited logo
Quotient Limited Reports Continued Progress on the Commercial Scale-up of MosaiQ™ and Second Quarter Fiscal 2017 Financial Results
October 31, 2016 16:15 ET | Quotient Limited
JERSEY, Channel Islands, Oct. 31, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today reported further progress on the commercial scale-up of...
Quotient Limited logo
Quotient Limited Announces Booth Tour at the 2016 AABB Annual Meeting and Provides Update of Expected Timing of Internal Evaluation Study Results
October 21, 2016 08:30 ET | Quotient Limited
JERSEY, Channel Islands, Oct. 21, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company’s executive management team will...
Quotient Limited logo
Quotient Limited to Report Second Quarter Fiscal 2017 Financial Results and Host Conference Call
October 17, 2016 08:30 ET | Quotient Limited
JERSEY, Channel Islands, Oct. 17, 2016 (GLOBE NEWSWIRE) -- Quotient Limited  (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal...
Quotient Limited logo
Quotient Limited Announces $120 Million Secured Debt Financing
October 14, 2016 16:01 ET | Quotient Limited
JERSEY, Channel Islands, Oct. 14, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (“Quotient”) (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the completion of a private...
Quotient Limited logo
Quotient Limited Announces Successful Validation of the Initial Manufacturing System for MosaiQ™ Microarrays
September 08, 2016 16:05 ET | Quotient Limited
MosaiQTM manufacturing system operating in accordance with design requirements Ongoing evaluation of MosaiQTM methodology continues to demonstrate concordance levels in excess of 99.0% for key blood...
Quotient Limited logo
Quotient Limited Reports Further Progress on the Commercial Scale-up of MosaiQ™ and First Quarter Fiscal 2017 Financial Results
August 08, 2016 16:15 ET | Quotient Limited
Facility modification completed – humidity control successfully resolved issue previously impacting final assembly of MosaiQ™ consumablesValidation of the initial manufacturing system for MosaiQ™...